Related Experiment Video
Updated: Jul 30, 2026

12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
An implantable aortic valvo-pump for destination therapy
1Institute of Biomedical Engineering, Jiangsu University, Zhenjiang , 212013, China. swyx@ujs.edu.cn
Cardiovascular Engineering (Dordrecht, Netherlands)
|August 11, 2006
Summary
A novel implantable aortic valvo-pump was developed for long-term heart support. This compact device directly pumps blood from the left ventricle to the aorta, showing promising antithrombogenicity and effective hemodynamic performance.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Medical Implants
Background:
- Heart failure necessitates advanced circulatory support systems.
- Existing left ventricular assist devices (LVADs) often require complex bypass circuits.
- Improving antithrombogenicity and device integration is crucial for long-term LVAD application.
Purpose of the Study:
- To develop and evaluate a novel, compact implantable aortic valvo-pump.
- To assess the hemodynamic performance and potential antithrombogenicity of the device.
- To investigate the feasibility of a long-term applicable left ventricular assist device without external conduits.
Main Methods:
- Development of a 23 mm outer diameter, 31 g implantable aortic valvo-pump.
- The device integrates a rotor with impeller and a stator with motor coil and guide vane.
- Hemodynamic testing to measure blood flow and pressure generation at various speeds.
Main Results:
- The valvo-pump directly delivers blood from the left ventricle to the aorta, eliminating the need for bypass circuits.
- Achieved a blood flow of 7 L/min with a 50 mmHg pressure increase at 15,000 rpm.
- Maintained a diastolic pressure over 80 mmHg at zero flow rate and the same rotational speed.
Conclusions:
- The developed aortic valvo-pump demonstrates promising antithrombogenicity due to its direct integration.
- The device shows effective hemodynamic function, supporting its potential as a long-term heart assist solution.
- Further investigation into blood compatibility and device durability is essential for clinical translation.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

